These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23041022)

  • 61. Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates.
    Bissielo A; Pierse N; Huang QS; Thompson MG; Kelly H; Mishin VP; Turner N;
    Euro Surveill; 2016; 21(1):. PubMed ID: 26767540
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Thompson MG; Pierse N; Sue Huang Q; Prasad N; Duque J; Claire Newbern E; Baker MG; Turner N; McArthur C;
    Vaccine; 2018 Sep; 36(39):5916-5925. PubMed ID: 30077480
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014.
    Turner N; Pierse N; Huang QS; Radke S; Bissielo A; Thompson MG; Kelly H;
    Euro Surveill; 2014 Oct; 19(42):. PubMed ID: 25358042
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16.
    Nohynek H; Baum U; Syrjänen R; Ikonen N; Sundman J; Jokinen J
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684447
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study.
    Puig-Barberà J; Arnedo-Pena A; Pardo-Serrano F; Tirado-Balaguer MD; Pérez-Vilar S; Silvestre-Silvestre E; Calvo-Mas C; Safont-Adsuara L; Ruiz-García M;
    Vaccine; 2010 Nov; 28(47):7460-7. PubMed ID: 20875486
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
    Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
    Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.
    Zhang Y; Wu P; Feng L; Yang P; Pan Y; Feng S; Qin Y; Zheng J; Puig-Barberà J; Muscatello D; MacIntyre R; Cowling BJ; Yu H; Wang Q
    Vaccine; 2017 May; 35(23):3129-3134. PubMed ID: 28456530
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.
    Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA
    Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network.
    de Lusignan S; Hoang U; Liyanage H; Tripathy M; Sherlock J; Joy M; Ferreira F; Diez-Domingo J; Clark T
    PLoS One; 2021; 16(3):e0248123. PubMed ID: 33705452
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project.
    Stuurman AL; Levi M; Beutels P; Bricout H; Descamps A; Dos Santos G; McGovern I; Mira-Iglesias A; Nauta J; Torcel-Pagnon L; Biccler J;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13087. PubMed ID: 36550627
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pandemic risk prevention in European countries: role of the ECDC in preparing for pandemics. Development and experience with a national self-assessment procedure, 2005-2008.
    Nicoll A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Dec; 53(12):1267-75. PubMed ID: 21161477
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication.
    Hollingsworth R; El Guerche-Séblain C; Tsai T; Vasiliev Y; Lee S; Bright H; Barbosa P
    Influenza Other Respir Viruses; 2021 Jan; 15(1):164-174. PubMed ID: 32885610
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009.
    Devaux I; Kreidl P; Penttinen P; Salminen M; Zucs P; Ammon A; ;
    Euro Surveill; 2010 Dec; 15(49):. PubMed ID: 21163182
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK.
    Stuurman AL; Ciampini S; Vannacci A; Bella A; Rizzo C; Muñoz-Quiles C; Pandolfi E; Liyanage H; Haag M; Redlberger-Fritz M; Bonaiuti R; Beutels P
    PLoS One; 2021; 16(6):e0252836. PubMed ID: 34129638
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs.
    Halme J; Syrjänen RK; Baum U; Palmu AA
    Vaccine; 2022 Jul; 40(31):4242-4252. PubMed ID: 35691869
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project.
    Carmona A; Muñoz-Quiles C; Stuurman A; Descamps A; Mira-Iglesias A; Torcel-Pagnon L; Díez-Domingo J
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33504081
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project.
    Paget J; Danielle Iuliano A; Taylor RJ; Simonsen L; Viboud C; Spreeuwenberg P;
    Vaccine; 2022 Feb; 40(9):1361-1369. PubMed ID: 35094868
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries.
    ECDC working group on influenza A(H1N1)v
    Euro Surveill; 2009 Jun; 14(23):19238. PubMed ID: 19531343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.